Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03691701 · ClinicalTrials.gov registry record · NA

Pilot to Examine Risk and Feasibility of Remote Management of BP From Childhood Into Early Adulthood

A NA study of Hypertension and Blood Pressure, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03691701 is a NA study of Hypertension and Blood Pressure that has completed, run by University of California, San Francisco. The registered enrollment target is 20 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03691701, a NA study of Hypertension and Blood Pressure, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Hypertension is an increasingly common problem in children, especially among those who are obese or with diabetes and chronic kidney disease. This study is a pilot randomized controlled trial designed to test whether improved blood pressure control can be achieved with the use of remote home blood pressure monitoring in children with uncontrolled blood pressure.

Interventions

  • OTHER strict blood pressure control

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-07-20
Est. Completion 2020-12-31
Phase NA

What the Registry Record Tells You About NCT03691701

The ClinicalTrials.gov registry entry for NCT03691701 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which strict blood pressure control is the first listed.

NCT03691701 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03691701 about?

NCT03691701 is a clinical study titled "Pilot to Examine Risk and Feasibility of Remote Management of BP From Childhood Into Early Adulthood". Hypertension is an increasingly common problem in children, especially among those who are obese or with diabetes and chronic kidney disease. This study is a pilot randomized controlled trial designed to test whether improved blood pressure control can be achieved with the use of remote home blood p...

What is the current status of trial NCT03691701?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-07-20. Estimated completion is 2020-12-31.

What conditions does trial NCT03691701 study?

This clinical trial studies the following conditions: Hypertension, Blood Pressure, Chronic Kidney Diseases.

What interventions are being tested in trial NCT03691701?

The interventions under investigation include: strict blood pressure control (OTHER).

Who is sponsoring clinical trial NCT03691701?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03691701 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.